QA108
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QA108, covering 2024-07-15 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: QA108 Phase III Study in Subjects With Intermediate AMD [Phase 3]